(Q71651736)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7523732%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

title

Can radical prostatectomy alter the progression of poorly differentiated prostate cancer? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7523732%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

Can Radical Prostatectomy Alter the Progression of Poorly Differentiated Prostate Cancer? (English)

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)32398-4

16 May 2024

1 reference

M. Ohori

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7523732

16 May 2024

J. R. Goad

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7523732

16 May 2024

T. M. Wheeler

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7523732

16 May 2024

J. A. Eastham

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7523732

16 May 2024

T. C. Thompson

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7523732

16 May 2024

P. T. Scardino

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7523732

16 May 2024

language of work or name

English

0 references

publication date

1 November 1994

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7523732%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

20 October 2019

https://api.elsevier.com/content/article/PII:S0022534717323984?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)32398-4

https://api.elsevier.com/content/article/PII:S0022534717323984?httpAccept=text/plain

16 May 2024

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)32398-4

http://www.jurology.com/doi/pdf/10.1016/S0022-5347%2817%2932398-4

16 May 2024

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)32398-4

16 May 2024

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7523732%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

volume

152

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7523732%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

issue

5 Pt 2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7523732%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

page(s)

1843-1849

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7523732%20AND%20SRC:MED&resulttype=core&format=json

Cause-specific actuarial survival analysis: a useful method for reporting survival data in men with clinically localized carcinoma of the prostate.

20 October 2019

cites work

1

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)32398-4

Total prostatectomy for clinically localized prostatic cancer: long-term results

16 May 2024

2

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)32398-4

Natural course of clinically localized prostate adenocarcinoma in men less than 70 years old.

16 May 2024

4

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)32398-4

A decision analysis of alternative treatment strategies for clinically localized prostate cancer. Prostate Patient Outcomes Research Team

16 May 2024

5

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)32398-4

Results of conservative management of clinically localized prostate cancer.

16 May 2024

6

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)32398-4

Long-term impact of conservative management on localized prostate cancer. A twenty-year experience in Japan

16 May 2024

7

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)32398-4

Radical prostatectomy for clinical stage T1-2N0M0 prostatic adenocarcinoma: long-term results

16 May 2024

8

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)32398-4

Cancer Control following Anatomical Radical Prostatectomy: An Interim Report

16 May 2024

11

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)32398-4

Prostate specific antigen levels after radical prostatectomy in patients with organ confined and locally extensive prostate cancer

16 May 2024

12

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)32398-4

Operable prostatic carcinoma: correlations among clinical stage, pathological stage, gleason histological score and early disease-free survival

16 May 2024

13

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)32398-4

The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer

16 May 2024

14

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)32398-4

Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging

16 May 2024

17

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)32398-4

Histologic grading of prostate cancer: a perspective

16 May 2024

18

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)32398-4

Correlation of pathologic findings with progression after radical retropubic prostatectomy

16 May 2024

19

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)32398-4

A comparison of the morphological features of cancer arising in the transition zone and in the peripheral zone of the prostate

16 May 2024

20

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)32398-4

The p53 tumour suppressor gene

16 May 2024

21

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)32398-4

Small Subgroup of Aggressive, Highly Proliferative Prostatic Carcinomas Defined by p53 Accumulation

16 May 2024

22

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)32398-4

p53 is mutated in a subset of advanced-stage prostate cancers

16 May 2024

23

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)32398-4

Is tumor volume an independent predictor of progression following radical prostatectomy? A multivariate analysis of 185 clinical stage B adenocarcinomas of the prostate with 5 years of followup

16 May 2024

24

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)32398-4

Histologic differentiation, cancer volume, and pelvic lymph node metastasis in adenocarcinoma of the prostate

16 May 2024

25

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)32398-4

Clinical Stage B0 or T1c prostate cancer: nonpalpable disease identified by elevated serum prostate-specific antigen concentration

16 May 2024

26

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)32398-4

Detection of organ-confined prostate cancer is increased through prostate-specific antigen-based screening

16 May 2024

28

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)32398-4

16 May 2024

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7523732%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

1 reference